Bio-Techne
TECH
#1983
Rank
S$10.40 B
Marketcap
$65.83
Share price
-1.35%
Change (1 day)
-23.87%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

EPS for Bio-Techne (TECH)

EPS in 2023 (TTM): $2.11

According to Bio-Techne's latest financial reports the company's current EPS (TTM) is $2.06. In 2022 the company made an earnings per share (EPS) of $2.20 an increase over its 2021 EPS that were of $1.77.

EPS history for Bio-Techne from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.11-3.78%
2022$2.2024.35%
2021$1.7717.98%
2020$1.50-10.94%
2019$1.68101.57%
2018$0.83-17.53%
2017$1.0139.37%
2016$0.73-17.23%
2015$0.88-14.97%
2014$1.031.29%
2013$1.023.68%
2012$0.98-1.97%
2011$1.001.67%
2010$0.997.14%
2009$0.92-1.06%
2008$0.9319.41%
2007$0.7819.1%
2006$0.6510.56%
2005$0.5929.5%
2004$0.4613.05%
2003$0.4068.43%
2002$0.24-17.05%
2001$0.2917.33%
2000$0.2548.51%
1999$0.1723.17%
1998$0.1313.89%
1997$0.1242.57%
1996$0.08295

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$20.16 877.07%๐Ÿ‡บ๐Ÿ‡ธ USA
-$7.52-464.33%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.29 253.50%๐Ÿ‡บ๐Ÿ‡ธ USA
$10.54 410.83%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.91-7.38%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
$11.24 444.59%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.24-159.87%๐Ÿ‡บ๐Ÿ‡ธ USA